About
About E2SMed
A clinical research investment and development company supporting the responsible advancement of selected biomedical and regenerative medicine research programs.
A clinical research investment and development company supporting the responsible advancement of selected biomedical and regenerative medicine research programs.
E2SMed Pty Ltd is an Australian clinical research investment and development company established to support the responsible advancement of selected biomedical and regenerative medicine research programs.
The company’s role is to help bridge the gap between scientific innovation, clinical evaluation and investment readiness. E2SMed does this by combining investment strategy, clinical trial planning, hospital relationships, medical governance and commercial development planning.
E2SMed focuses on clinical research programs where there is:
E2SMed may act as a clinical research investment platform, project development partner, clinical trial sponsor or commercialisation vehicle, depending on the requirements of each program.